Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.61M Sell
10,971
-1,258
-10% -$204K 0.11% 166
2025
Q4
$2.38M Sell
12,229
-2,171
-15% -$517K 0.17% 125
2025
Q3
$4.05M Sell
14,400
-241
-2% -$61.4K 0.3% 83
2025
Q2
$3.2M Sell
14,641
-184
-1% -$29.7K 0.26% 94
2025
Q1
$2.07M Buy
14,825
+3,004
+25% +$489K 0.19% 120
2024
Q4
$1.97M Sell
11,821
-473
-4% -$84K 0.21% 109
2024
Q3
$2.09M Buy
12,294
+3,360
+38% +$487K 0.23% 106
2024
Q2
$1.26M Buy
8,934
+510
+6% +$63.3K 0.15% 133
2024
Q1
$1.06M Buy
8,424
+2,703
+47% +$309K 0.14% 140
2023
Q4
$603K Buy
5,721
+2,463
+76% +$269K 0.1% 185
2023
Q3
$345K Buy
3,258
+1,047
+47% +$121K 0.1% 136
2023
Q2
$263K Buy
+2,211
New +$229K 0.08% 151

Other funds holding ORCL

Waterloo Capital's ORCL Position: Q1 2026 in Review

Waterloo Capital reduced its Oracle (ORCL) stake by 10% in Q1 2026, selling an estimated $204K and leaving 10,971 shares worth $1.61M. The position accounts for 0.11% of the portfolio, ranked #166.

Waterloo Capital first reported a position in ORCL in Q2 2023 and has held it in 12 quarters since. The position peaked at $4.05M in Q3 2025. 3,473 funds tracked by Wall St. Rank hold ORCL as of Q1 2026.

  • Waterloo Capital held 10,971 shares of Oracle worth $1.61M as of Q1 2026.
  • Waterloo Capital sold 1,258 Oracle shares in Q1 2026, an estimated $204K.
  • Oracle made up 0.11% of Waterloo Capital's portfolio in Q1 2026, its #166 holding.
  • Waterloo Capital first reported a position in Oracle in Q2 2023 and has held it in 12 quarters since.
  • Waterloo Capital's Oracle position peaked at $4.05M in Q3 2025.
  • 3,473 funds tracked by Wall St. Rank held Oracle as of Q1 2026.

Based on Waterloo Capital's 13F filing for Q1 2026, filed 12 May 2026.